Literature DB >> 15722196

Direct interactions among Ret, GDNF and GFRalpha1 molecules reveal new insights into the assembly of a functional three-protein complex.

Angela Amoresano1, Mariarosaria Incoronato, Gianluca Monti, Piero Pucci, Vittorio de Franciscis, Laura Cerchia.   

Abstract

The glial-cell-line-derived neurotrophic factor (GDNF) ligand activates the Ret receptor through the assembly of a multiprotein complex, including the GDNF family receptor alpha1 (GFRalpha1) molecule. Given the neuroprotective role of GDNF, there is an obvious need to precisely identify the structural regions engaged in direct interactions between the three molecules. Here, we combined a functional approach for Ret activity (in PC12 cells) to cross-linking experiments followed by MS-MALDI to study the interactions among the purified extracellular region of the human Ret, GDNF and GFRalpha1 molecules. This procedure allowed us to identify distinct regions of Ret that are physically engaged in the interaction with GDNF and GFRalpha1. The lack of these regions in a recombinant Ret form results in the failure of both structural and functional binding of Ret to GFRalpha1/GDNF complex. Furthermore, a model for the assembly of a transducing-competent Ret complex is suggested.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15722196     DOI: 10.1016/j.cellsig.2004.10.012

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

Review 1.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 2.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

3.  A common RET variant is associated with reduced newborn kidney size and function.

Authors:  Zhao Zhang; Jackie Quinlan; Wendy Hoy; Michael D Hughson; Mathieu Lemire; Thomas Hudson; Pierre-Alain Hueber; Alice Benjamin; Anne Roy; Elena Pascuet; Meigan Goodyer; Chandhana Raju; Fiona Houghton; John Bertram; Paul Goodyer
Journal:  J Am Soc Nephrol       Date:  2008-10       Impact factor: 10.121

Review 4.  Structure and physiology of the RET receptor tyrosine kinase.

Authors:  Carlos F Ibáñez
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

5.  The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding.

Authors:  Vimal Parkash; Veli-Matti Leppänen; Heidi Virtanen; Jaana M Jurvansuu; Maxim M Bespalov; Yulia A Sidorova; Pia Runeberg-Roos; Mart Saarma; Adrian Goldman
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

6.  Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis.

Authors:  Gretchen Dole; Eric E Nilsson; Michael K Skinner
Journal:  Reproduction       Date:  2008-02-27       Impact factor: 3.906

Review 7.  Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.

Authors:  Simona M Wagner; ShuJun Zhu; Adrian C Nicolescu; Lois M Mulligan
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation.

Authors:  Carla Lucia Esposito; Amelia D'Alessio; Vittorio de Franciscis; Laura Cerchia
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

Review 9.  Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Biomark Insights       Date:  2018-07-02

10.  Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction.

Authors:  Nicole A Gabreski; Janki K Vaghasia; Silvia S Novakova; Neil Q McDonald; Brian A Pierchala
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.